Merck Launches Gardasil In Japan
This article was originally published in PharmAsia News
Executive Summary
Merck Sharp & Dohme Japan has launched the second cervical cancer vaccine Gardasil (human papillomavirus vaccine (Types 6, 11, 16, and 18) in Japan